Ausgabe Sonderheft 1/2011
Proceedings of 18th Pediatric Rheumatology European Society (PReS) Congress
Inhalt (360 Artikel)
Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
AM Pesenacker, Stavroula Zavitsanou, Kiran Nistala, Lucy R Wedderburn
CD4+FOXP3+ regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
Yvonne Vercoulen, Elisabeth F Elst, Jenny Meerding, Maud Plantinga, Hemlata Varsani, Christa van Schieveen, Mette H Bakker, Mark Klein, Wim Spliet, R de Weger, Lucy Wedderburn, Annet van Royen-Kerkhof, Berent J Prakken
Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
Kim Ohl, Ralph Lippe, Eva Verjans, Nora Honke, Karin Maschke-Neuss, Norbert Wagner, Johannes Roth, Klaus Tenbrock
Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
Pieter E H Van Dijkhuizen, Maja Bulatović, Marloes W Heijstek, Nico M Wulffraat, Saskia M F Pluijm, Robert de Jonge
Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Sergio Davì, Bianca Lattanzi, Silvia Rosina, Erkan Demirkaya, Nicolino Ruperto, Alberto Martini, Randy Q Cron, Angelo Ravelli
Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis
SJ Vastert, W De Jager, BJ Noordman, D Holzinger, W Kuis, BJ Prakken, NM Wulffraat
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells
EJ Wehrens, G Mijnheer, B Vastert, M Klein, J van Loosdregt, W de Jager, PJ Coffer, BJ Prakken, F van Wijk
Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
S Ursu, H Moncrieffe, H Varsani, RHB Hamaoui, L Beard, L Kassoumeri, F Patrick, LR Wedderburn
Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism
G Minnone, R Strippoli, G Prencipe, L De Pasquale, C Bracaglia, A Insalaco, F De Benedetti, L Bracci-Laudiero
Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
H Moncrieffe, D Holzinger, S Ursu, F Patrick, L Kassoumeri, J Roth, LR Wedderburn
Comparison of CNS vasculitis in children and adults; is this the same disease entity
Marinka Twilt, Carlo Salvarani, Tania Cellucci, Gene Hunder, Susanne Benseler
MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
C Malattia, A Consolaro, S Pederzoli, MB Damasio, R Hasija, M Mazzoni, A Madeo, A Beltramo, S Viola, A Buoncompagni, C Mattiuz, A Ravelli, A Martini
Increased percentages of calprotectin and TNF-Α double-positive monocytes in the acute phase of Kawasaki disease
Rolando Cimaz, Giuliana Guggino, Salvatore Accomando, Gabriele Simonini, Ilaria Pagnini, Eiji Ohtsu, Tomisaku Kawasaki, Francesco Dieli, Mahavir Singh, Guido Sireci
Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender
S Venkatesan, NG Lawrence, C Carbone, E Jaeggi, ED Silverman, S Kamphuis
Preliminary validation of the paediatric vasculitis activity score (PVAS)
Fiona E Price-Kuehne, Despina Eleftheriou, Seza Ozen, Michael Beresford, Pavla Dolezalova, Paul A Brogan
Long-term methotrexate efficacy in juvenile localized scleroderma
F Zulian, C Vallongo, F Vittadello, G Zanon, S Giuliotto, G Martini
Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
Rina Mina, Laura Schanberg, Anne B Eberhard, Marisa Klein–Gitelman, Gloria Higgins, Karen Onel, Nora G Singer, Kathleen O’Neil, Lori Tucker, Deborah Levy, Wajeeha Yousaf, Shannen Nelson, Michael Beresford, Ruben Cuttica, Graciela Espada, Angelo Ravelli, Alberto Martini, Edward Giannini, Hermine I Brunner
Patients with early-onset systemic juvenile idiopathic arthritis show more inflammation and worse outcome
R Russo, M Katsicas
Analysis of growth in female patients with pediatric-onset systemic lupus erythematosus
NC Mak, C Carbone, LS Lim, DM Levy, ED Silverman, S Kamphuis
Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
Nur Canpolat, Ozgur Kasapcopur, Salim Caliskan, Selman Gokalp, Meltem Bor, Mehmet Tasdemir, Lale Sever, Nil Arisoy
Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study
N Ruperto, H Brunner, G Horneff, P Quartier, T Constantin, Y Berkun, M Erguven, T Kallinich, R Brik, NM Wulffraat, MA Ferrandiz, L Rutkowska-Sak, H Ozdogan, L McCann, K Lheritier, R Preiss, L Tseng, A Martini, DJ Lovell
Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
M Bertamino, A Consolaro, B Lattanzi, S Magni-Manzoni, S Lanni, C Suffia, S Dalprà, S Rosina, A Martini, A Ravelli
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
M Verkaaik, M Bulatović, G Sinnema, C Rademaker, NM Wulffraat
To evaluate the impact of a nurse-led JIA education program on parental satisfaction regarding knowledge of JIA and its management
J Jones, J Munro, T Williams, A Augustine, K Taylor, S Piper, R Allen, J Akikusa
Identification of Blau Syndrome disease signatures
KP Foley, L Wang, D Cooper, M Magid-Slav, D Lipshutz, J Connor, M Miller, B Votta, P Gough, X Valencia, CH Wouters, CD Rosé, J Bertin
Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis
N Ruperto, DJ Lovell, A Reiff, M Gamir, G Higgins, I Koné-Paut, OY Jones, E Chalom, N Ilowite, C Wouters, MJ McIlraith, S Liu, H Kupper, EH Giannini, A Martini
Safety and efficacy of ultrasound guided corticosteroid injections into temporomandibular joints in children with active juvenile idiopathic arthritis
S Habibi, J Ellis, H Strike, AV Ramanan
Etanercept in juvenile idiopathic arthritis: Who will benefit?
MH Otten, FHM Prince, W Armbrust, R ten Cate, EPAH Hoppenreijs, M Twilt, Y Koopman-Keemink, SL Gorter, KM Dolman, JF Swart, JM van den Berg, NM Wulffraat, MAJ van Rossum, LWA van Suijlekom-Smit
Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis
EL Boulter, L Beard, C Ryder, CA Pilkington
Characterization of tonsil infiltration and gene expression profile of innate sensors in PFAPA patients
S Chiesa, MA Pelagatti, M Finetti, I Prigione, R Caorsi, D Lasiglié, R D’Agostino, A Sementa, A Omenetti, E Traggiai, A Martini, M Gattorno
Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
Isabelle Jeru, Véronique Hentgen, Sylvain Normand, Philippe Duquesnoy, Emmanuelle Cochet, Adriana Delwail, Gilles Grateau, Sandrine Marlin, Serge Amselem, Jean-Claude Lecron
International cohort study for pediatric Behçet’s Disease: update 2011
I Koné-Paut, M Darce Bello, F Shahram, M Gattorno, R Cimaz, B Chkirate, K Bouayed, M Hofer, S Ozen, J Anton, I Tugal Tutkum, J Kümmerle-Deschner, S Benamour, S Assad Khalil, L Cantarini, A Faye, A Letierce, TA Tran, F Davatchi, O Kasapcopur, A Al Mayouf, C Pajot, S Nielsen, L Lepore, W Bono
Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients
W de Jager, SJ Vastert, BJ Noordman, D Holzinger, W Kuis, BJ Prakken, NM Wulffraat
Creation of a cohort of French patients with chronic recurrent multifocal osteitis : preliminary results
J Wipff, MA Dumitrescu, M Lorrot, S Kettani, A Faye, S Lacassagne, B Bader-Meunier, R Mouy, C Wouters, M Desjonquères, S Jean, V Despert, A Duquesne, I Lemelle, P Pillet, M Grall-Lerosey, P Quartier, C Job-Deslandre
The frequency of parent-reported motor coordination difficulties in children diagnosed with benign joint hypermobility syndrome
C Bernie, SM Maillard
The development of a new service for the management of Non-inflammatory Musculoskeletal Pain
S Bhagat, C Bernie, A Morgan, C Pilkington, SM Maillard
Analgesia for joint punctures in children - experiences with a nitrous oxide / oxygen mixture (LIVOPAN®)
Thilo Schmalbach, Gerd Horneff
Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
PJ Hashkes, SJ Spalding, EH Giannini, B Huang, G Park, KS Barron, MH Weisman, N Pashinian, AO Reiff, J Samuels, D Wright, DL Kastner, DJ Lovell
A novel mutatioin in the PSTPIP1 gene is associated with an autoinflammatory disease distinct from classical PAPA syndrome
D Holzinger, J Austermann, P Lohse, I Aksentijevich, S Holland, M Gattorno, C Rodríguez-Gallego, S Fessatou, B Isidor, S Tokio, J Bernstein, B Sampson, C Sunderkoetter, J Roth
Toll-like receptor 2 polymorphism in juvenile dermatomyositis
P Mathiesen, C Enevold, T Lange, B Kornblit, S Nielsen, K Müller
Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
MW Heijstek, N Groot, M Scherpenisse, C Tacke, G Berbers, F van der Klis, NM Wulffraat
Predictors of disability in children with inflammatory arthritis, two and three years after first presentation to paediatric rheumatology. Results from the childhood arthritis prospective study (CAPS)
R Carrasco, J Cobb, E Baildam, H Foster, J Gardner-Medwin, A Chieng, L Wedderburn, J Davidson, K Hyrich, W Thomson
Increasing self-efficacy – the effectiveness of a pain management programme for children and parents
A Morgan, N Levi, C Bernie
National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
C Bibalo, G Paloni, L Lepore, M Gattorno, M Finetti, F Zulian, G Martini, M Alessio, M Cattalin, A Stabile, D Rigante, A Insalaco, R Manna, R Gallizzi, L Obici, L Cantarini, S Martino, R Cionsolini
Amyloidosis in a child with Hyperimmunoglobulin D syndrome
Ruhan Dusunsel, Zubeyde Gunduz, Funda Bastug, Ismail Dursun, Hakan M Poyrazoglu, Sibel Yel, Sebahat Tulpar, Kemal Deniz, Erkan Demirkaya
Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
SO Salugina, ES Fedorov, NN Kuzmina
Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
MS Camacho Lovillo, E Iglesias, O Neth, V Santa-María, JL Gavilán
Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
MS Camacho Lovillo, E Iglesias, O Neth, V Santa-María, A Sánchez, J Bernabeu
Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
C Galeotti, A Boucheron, S Guillaume, I Koné-Paut
Interleukin-1 antagonists in Mevalonate Kinase Deficiency
C Galeotti, L Rossi-Semerano, S Guillaume, A Duquesne, P Pillet, O Richer, E Hachulla, I Koné-Paut
A case of early onset renal sarcoidosis complecated with multiple enchondromatosis
U Kaneko, S Toyabe, M Uchiyama
A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to V198M mutation responds to canakinumab - a case report
Sandra Hansmann, Christiane Zimmer, Monika Moll, Nikolaus Rieber, Jasmin B Kuemmerle-Deschner
A case of autoimmune lymphoproliferative syndrome in a 3 years-old patient
IN Lavrentieva, SR Rodionovskaya, IN Tsymbal, MA Maschan, TA Visotskaya
Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
Onur Akin, Erkan Demirkaya, Adem Polat, Ezgi Deniz Batu, Yusuf Tunca, Cengizhan Acikel, Harun Peru, Betul Sozeri, Ismail Dursun, Hakan Poyrazoglu, Faysal Gok, Seza Ozen
Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
B Bader-Meunier, P Hachulla, J Kuemmerle-Deschner, M Gattorno, N Patel, R Preiss, K Lheritier, T Imagawa, R Nishikomori, H Takada, T Heike, T Hara, S Yokota
Our experience with the use of the Interleukin-1 receptor antagonist in the treatment of the patient with CINCA/NOMID syndrome (case study - 5 years of therapy)
V Vargova, Z Macejova
Hypofertility in Muckle Wells syndrome and treatment with IL-1 targeting drugs
Ulrich Meinzer, Isabelle Marie, Isabelle Koné-Paut, Tu-Anh Tran
Therapy of autoinflammatory diseases: a review of the literature
NM ter Haar, J Frenkel
β-Confident-registry: aiming to be largest-ever studied cohort of cryopyrin-associated periodic syndromes (CAPS) patients. Study design and baseline characteristics
J Kuemmerle-Deschner, D Rothenbacher, U Walker, H Tilson, H Hoffman, P Hawkins
FMF in heterozygotes: are we able to accurately diagnose the disease in very young children?
Véronique Hentgen, Katia Stankovic Stojanovic, Gilles Grateau, Serge Amselem, Isabelle Jeru
Therapy of autoinflammatory diseases: results from an international registry
NM ter Haar, J Frenkel, P Woo, L Cantarini, H Lachmann, A Insalaco, M Hofer, Y Uziel, S Ozen, S Nielsen, A Naselli, C Modesto, SM Al-Mayouf, I Kone-Paut, I Nikishina, N Iagaru, L Obici, E Papadopoulou-Alataki, D Rigante, C Boros, A Martini, N Ruperto, M Gattorno
Behçet disease: evaluation of clinical manifestations in Turkish children
Erkan Demirkaya, Celal Saglam, Turker Turker, Sevcan Bakkaloglu, Balahan B Makay, Bora Gulhan, Banu Acar, Nuray A Ayaz, İsmail Dursun, Adem Polat, Cetin Kocabiyik, Faysal Gok, Erbil Unsal, Ozgur Kasapcapur, Seza Özen
Survey of off-label anti-IL1 treatments in France: preliminary data
L Rossi-Semerano, B Fautrel, C Galeotti, I Koné-Paut
Hyper-IgD syndrome: a new mutation (p.R277G) with a severe phenotype
J Santos, JI Arostégui, MJ Brito, C Neves, M Conde
Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
R Caorsi, L Lepore, F Zulian, M Alessio, A Stabile, M Finetti, A Martini, M Gattorno
Chronic nonbacterial osteomyelitis in children
A Desdoits, S Gandon-Laloum
Impact of mevalonate kinase deficiency (MKD) on the quality of life in children and young adults: a national multicentre study
Silvia Federici, Alberto Tomasini, Antonella Meini, Matteo Doglio, G Calcagno, Francesco Zulian, Rita Consolini, Martina Finetti, Luciana Breda, Roberta Caorsi, Laura Obici, Romina Gallizzi, Donato Rigante, Mariolina Alessio, Alberto Martini, Marco Gattorno
Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes
F Zulian, G Vigo, F Vittadello, I Ceccherini, L Obici, G Martini
Tonsillectomy efficacy is comparable to the standard medical treatment in PFAPA syndrome
G Vigo, G Martini, S Zoppi, F Vittadello, F Zulian
Mc Cune Albright syndrome: estimation of bone strength parameters and response to treatment using peripheral Quantitive Computed Tomography (pQCT) of the tibia
E Atsali, KD Stathopoulos, E Stefos, H Bournazos, G Kiniklis, A Papadimitriou, P Nicolaidou, AB Zoubos, G Skarantavos
Phalangeal microgeodic syndrome, a case series
J Toelen, T Van Ackere, S Brijs, A Brijs, A Eykens, P Maroteaux, C Wouters
Diagnostic difficulties in patients with attenuated form of MPS VI
V Opoka – Winiarska, A Jurecka, A Tylki – Szymańska, A Emeryk
ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children
Assunta CH Ho, Joannie Hui, KH Chan, KL Liu, Bobby KW Ng, Ivan FM Lo, STS Lam
Unifocal and multifocal chronic non-bacterial osteomyelitis (CNO) in children
G Zanon, A Insalaco, G Martini, S Corradin, P Zucchetta, L Tanturri, M Garganese, F De Benedetti, F Zulian
Description Kelley-Seegmiller syndrome (partial HPRT deficiency manifesting as a gout-urolithiasis syndrome) in a patient of 15 years old
SR Rodionovskaya, NZ Zokirov, ES Fedorov, IN Tsymbal, SO Salugina, MS Eliseev
Type 1 diabetes associated with Hashimoto’s thyroiditis and juvenile rheumatoid arthritis : a case report
Antonio Mellos, Angela Mauro, Milena Di Meglio, Carmela Granato, Laura Perrone, Alma N Olivieri
An atypical presentation of pyoderma gangrenosum with systemic features and pulmonary involvement in a toddler
Despoina Maritsi, Christina Neila, Millie Konstantinidou, Elizabeth Dimitriou
Aortoarteritis and cardiomyopathy in a child with Blau Syndrome
RP Khubchandani, RP Hasija, I Touitou, C Khemani
Experience with pediatric sarcoidosis at a centre in Mumbai, India
RP Khubchandani, RP Hasija, I Touitou, C Khemani
Pediatric sarcoidosis: report of seven cases
Yépez Ricardo, Malagon Clara, Olmos Carlos
Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies
D Moshous, I Meyts, S Fraitag, C Janssen, M Debré, F Suarez, J Toelen, K De Boeck, T Roskams, A Deschildre, C Picard, C Bodemer, C Wouters, A Fischer
Quality of life in patients with juvenile arthritis: adalimumab might make a difference
Rina Denisova, Ekaterina Alexeeva, Saniya Valieva, Tatyana Bzarova, Elena Mitenko, Tatyana Sleptsova, Kseniya Isayeva
Ultrasonography and colour Doppler in juvenile idiopathic arthritis: Diagnosis and follow-up of ultrasound-guided steroid injection in the wrist
Louise Laurell, Michel Court-Payen, Susan Nielsen, Marek Zak, Anders Fasth
Musculo-skeletal Ultrasound in paediatric rheumatology: experience of one University Hospital
J Madruga Dias, M Manuela Costa, F Saraiva, JA Pereira da Silva
Articular Doppler ultrasonography in juvenile idiopathic arthritis in remission: a prospective study
Maria Teresa Terreri, Vanessa Bugni, Carolina Tavares, Sônia Mitraud, Rita NV Furtado, Jamil Natour, Maria Odete Hilário
Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography
D Pradsgaard, A Spannow, C Heuck, A Hørlyck, T Herlin
Recurrent swelling of right knee: a case of hemangioma
J Wipff, H Guerini, C Deslandre
Sacroilitis on magnetic resonance imaging in children presenting with low backache: interobserver reliability between radiologists
Athimalaipet Ramanan, Shabina Habibi, M Thyagarajan, M Bradley
Musculoskeletal ultrasound (MSK-US) in pediatric rheumatology: European preliminary results of the survey of the Pediatric Ultrasound Group of the Omeract Ultrasound Task Force
Silvia Magni-Manzoni, Johannes Roth, Paz Collado, Esperanza Naredo, Maria Antonietta D'Agostino, Pietro Merli, Valentina Muratore, Sandrine Jousse-Joulin
MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
C Malattia, A Consolaro, S Pederzoli, MB Damasio, R Hasija, M Mazzoni, A Madeo, A Beltramo, S Viola, A Buoncompagni, C Mattiuz, A Ravelli, A Martini
Thrombotic microangiopathy in juvenile dermatomyositis
A Frolenko, N Bervina, M Kagan
Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
E Iglesias, J Antón, S Ricart, J Ros, V Torrente, R Bou, MA González, A Vicente
Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
Liza J McCann, Clarissa Pilkington, Laura Beard, Angelo Ravelli, Adam Huber, Lucy R Wedderburn
Juvenile dermatomyositis in Western Switzerland
F Bellutti Enders, M Hofer
Disease patterns in juvenile dermatomyositis patients from Mumbai, India
RP Khubchandani, D Mankad, PR Chickermane
Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
Violetta Opoka – Winiarska, Renata Jawniak, Andrzej Emeryk
Calcinosis as a complication of juvenile dermatomyositis (JDM)
Malagón Clara, Yépez Ricardo, Contreras Luz
Juvenile dermatomyositis associated to lymphoepithelioma, a nasopharyngeal carcinoma
BERG Bica, CT França, AB Vargas
Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland
N Martin, LR Wedderburn, JE Davidson, L Beard, CA Pilkington
Dyslipidemia in active juvenile dermatomyositis patients
KT Kozu, CA Silva, EF Borba, AME Sallum, VST Viana, LMA Campos
Inflammatory myositis in the pediatric rheumatology clinical practice – a case series
S Melo Gomes, M Conde, MP Ramos, JA Melo Gomes
Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report
Selmanovic-Mulaosmanovic Velma, Dizdarevic-Omercahic Aida, Mornjakovic-Franca Amela, Cengic Adisa
Development and initial validation of a new functional ability tool for juvenile dermatomyositis
GC Varnier, A Consolaro, C Malattia, AP Rao, A Madeo, E Demirkaya, D Lazarevic, A Civino, A Martini, A Ravelli
Juvenile dermatomyositis (JDM) sine myositis
C Schuetz, V Mohr, C Pfeiffer, A Schulz, KM Debatin
CD4+FOXP3+ regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
Yvonne Vercoulen, Elisabeth F Elst, Jenny Meerding, Maud Plantinga, Hemlata Varsani, Christa van Schieveen, Mette H Bakker, Mark Klein, Wim Spliet, R de Weger, Lucy Wedderburn, Annet van Royen- Kerkhof, Berent J Prakken
Off-label use of biological agents in the management of uveitis: experience from a pediatric rheumatology centre
Raquel Campanilho-Marques, Ana Filipa Mourão, Sónia Melo Gomes, João Eurico Fonseca, Helena Canhão, Carla Macieira, Filipa Ramos, JA Pereira da Silva
Mesenchymal stem cells and JIA
JF Swart, S de Roock, F Hofhuis, W Kuis, BJ Prakken, AC Martens, I Slaper-Cortenbach, NM Wulffraat
Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
Arina Lazareva, Valda Stanevicha, Jelizaveta Semjonova, Ruta Shantere, Inita Buliņa
Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
TA Tran, JC Lecron, D Pariente, I Jéru, A Delwail, I Kone-Paut, U Meinzer
Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center
G Espada, SM Meiorin, L Guerini, M Alvarez, Giupponi
B cells depletion as a value alternative therapeutic in pediatric autoimmune disorders: 3 case reports
Joana Extreia, Inês Marques, Paula Afonso, Joaquim Rodrigues, Nuno Fernandes, Vera Silva
Biologicals acting against interleukin 1 may reduce corticosteroid dependence in systemic onset juvenile idiopathic arthritis
W Emminger, A Ulbrich, E Pernetzky-Hintringer
Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
I Marvillet, I Calvo Penadés, B López Montesinos, A Marco Puche
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
G Espada, J Giupponi, C Cerqueiro
When is a autologous bone marrow transplantation indicated in the treatment of juvenile systemic sclerorsis? Results of a multinational survey of Pediatric Rheumatologist
Ivan Foeldvari, Angela Wierk, Dominique Farge
Preliminary results for 6 minute walk values in healthy German children
Ivan Foeldvari, Günther W Himmelmann
Juvenile localized scleroderma: review of 44 patients
E Iglesias, J Antón, S Ricart, J Ros, V Torrente, R Bou, MA González, A Vicente
Decreased digital skin microvascular blood flow before and after cold stimulus using Laser Doppler imaging in juvenile systemic sclerosis
Maria Teresa RATerreri, Daniela Gerent Petry Piotto, Marcelo José Uchôa Corrêa, Cristiane Kayser, Claudio Len
Autologous stem cell transplantation in two children with disabling pansclerotic morphea
M Moll, U Holzer, C Zimmer, N Rieber, JB Kuemmerle-Deschner
Childhood morphea does not impair self-perception
R Carlomagno, G Russo, C Forni, F Orlando, R Vitale, N Scotti, M Alessio
Linear scleroderma en coup the sabre, progressive facial hemiatrophy and Rasmussen encephalitis : a single disease spectrum?
M Morren, C Despontin, C Wouters
Cutaneous PAN and Common Variable Immunodeficiency: what causes what?
Ilaria Pagnini, Gabriele Simonini, Francesca Lippi, Chiara Azzari, Rolando Cimaz
Kawasaki disease in a northern region of Italy
Elena Corinaldesi, MFabi, G Savorelli
Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
YO Kostina, GA Lyskina, GM Rabieva, EV Uspenskaya
Increased serum Interleukin-18 in the active phase of Henoch-Schönlein purpura
Donato Rigante, Anna Zampetti, Giulia Bersani, Beatrice Bartolomei, Claudio Feliciani, Achille Stabile
Role of CD4+CD25hiCD127lo/-FoxP3+ regulatory T lymphocytes in the pathogenesis of Behçet’s disease in children
TA Tran, S Monteil, A Letierce, B Terrier, G Geri, D Saadoun, I Kone-Paut, B Salomon, M Rosenzwajg
Moyamoya disease. An important differential diagnosis to cerebral vasculitis
A Estmann, P Toftedal, AJ Schou
Coronary artery abnormalities in Kawasaki disease according to patient age
Esmeralda Nuñez, Patricia Martínez, Victorio Cuenca, Francisco Jesus García, David Moreno, Antonio Urda
An 11-year-old boy with long lasting headaches
Olga Vougiouka, Venetia-Maria Vraila, Lydia Kossiva, Dimitra Kallinikou, Dimitrios Kafetzis
Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
AS Sacri, B Ranchin, B Florkin, H See, T Ulinski, H Flodrops, S Decramer, R Salomon, P Quartier, J Harambat
Brazilian multicentre study of Takayasu’s arteritis in children and adolescents – preliminary results of a clinical, imaging and therapeutic study
Maria Teresa Terreri, Gleice Clemente, Sheila K Oliveira, Marise Lessa, Clóvis Artur Silva, Adriana Sallum, Lúcia Campos, Flávio Sztajnbok, Rosana Gasparello, André Cavalcanti, Virginia Ferriani, Teresa Robazzi, Silvana Sacchetti, Maria Odete Hilário
Cutaneous polyarteriitis nodosa with Grave’s disease and cholestatic liver disease
V Vassileva, B Varbanova
Imunological and clinical characteristics in children with polyarteritis nodosa: a retrospective study over the last 20 years
Masa Vikic Topic, Ivan Malcic, Danica Batinic, Danko Milosevic, Mandica Vidovic, Katarina Starcevic, Kristina Potocki, Branko Malenica, Marija Jelusic-Drazic
Disease activity in paediatric vasculitis: development of a generic assessment tool - PVAS
P Dolezalova, PA Brogan, S Özen, S Benseler, J Anton, J Brunner, DA Cabral, R Cimaz, KM O´Neil, C Wallace, N Wilkinson, R Luqmani
Primary systemic vasculitis in children in Estonia: a retrospective study from 2001-2010
Sirje Tarraste, Mari Laan, Jaanika Illison, Chris Pruunsild
Primary angiitis of the central nervous system in children - case series
V Krakovská, R Stibitzová, T Pískovský, Z Vrábelová, M Macků, D Němcová, P Doležalová
ANCA-associated vasculitides in childhood
Diána Garan, Zsófia Bence, Zsófia Gács, András Szabó, Tamás Constantin
Unusual presentations of Churg Strauss syndrome in paediatrics: a tale of 2 masses from one centre experience
E Baildam, C Pain, F McErlane, G Cleary, M Beresford, L McCann
Outcome of children with panarteritis nodosa: a series of 30 cases
E Merlin, R Mouy, P Quartier
Recurrent refractory Kawasaki disease
P Costa Reis, S Nativ, A Starr, L Imundo, A Eichenfield
Unusual organ involvment in Henoch–Schönlein purpura patients; a roprt from Iran
Vahid Ziaee, Mohamad-Hassan Moradinejad
Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
LA Katargina, EV Denisova, AV Starikova, NV Lubimova, IP Nikishina
Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Sergio Davì, Bianca Lattanzi, Silvia Rosina, Erkan Demirkaya, Nicolino Ruperto, Alberto Martini, Randy Q Cron, Angelo Ravelli
Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism
G Minnone, R Strippoli, G Prencipe, L De Pasquale, C Bracaglia, A Insalaco, F De Benedetti, L Bracci-Laudiero
Genetic susceptibility to juvenile idiopathic arthritis in Iranian children
Reza Shiari, Shirin Farivar, Elham Hadia
A novel therapeutic approach for macrophage actıvatıon syndrome due to SoJIA
Nuray Aktay Ayaz, Esra Şevketoğlu, Sait Serdar Oral, Tuğba Kontbay, Deniz Aybar, Sami Hatipoğlu, Gönül Aydoğan
Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
EH Pieter Van Dijkhuizen, Maja Bulatović, Marloes W Heijstek, Nico M Wulffraat, Saskia MF Pluijm, Robert de Jonge
Comparative characteristic of quality of life with patients suffering from juvenile idiopathic arthritis (JIA), attending school and taught at home
TA Shelepina, NY Stepanenko, ES Fedorov
Down regulation of anti-inflammatory cytokines in ileal mucosa associates with active disease in juvenile idiopathic arthritis
Miika Arvonen, Paula Vähäsalo, Sami Turunen, Harri Salo, Outi Vaarala, Tuomo J Karttunen
Serum tumor necrosis factor alpha increased during remission with Etanercept
Mihaela Spirchez, Gabriel Samasca, Claudia Bolba, Nicolae Miu
Interleukin-6 overproduction correlates with disease activity and severity in juvenile idiopathic arthritis
Mihaela Spirchez, Gabriel Samasca, Claudia Bolba, Nicolae Miu
Update of the results of a multinational survey regarding diagnosis and treatment of the temporomandibulare joint involvement in juvenile idiopathic arthritis- reflection of the day to day practice
Ivan Foeldvari, Nikolay Tzaribachev, Angela Wierk, Randy Cron
Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment
C Modesto, F Caracsegui, S Melendo, A Sanchez-Montanez, Manel Roig
In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
Rolando Cimaz, Lorenzo Cosmi, Laura Maggi, Gabriele Simonini, Teresa Giani, Ilaria Pagnini, Veronica Santarlasci, Manuela Capone, Valentina Querci, Francesco Liotta, Enrico Maggi, Francesco Annunziato
Early treatment with infliximabin patients with juvenile idiopathic arthritis
TV Sleptsova, EI Alexeeva, SI Valieva, TM Bzarova, KB Isayeva, RV Denisova, EV Mitenko
MRI evaluation of clinical remission in juvenile idiopathic arthritis
M van Veenendaal, R Hemke, MI Bos, M Maas, MAJ van Rossum, TW Kuijpers
A biopsychosocial approach to parents of children with juvenile idiopathic arthritis
Z Georgiadou, M Trachana, P Pratsidou-Gertsi, G Pardalos, M Stavrakidou, I Karagiannaki
The role of clinical pilates exercises in children wıth juvenile idiopathic arthritis: a pilot study
Edibe Unal, Pinar Dizmek, Yelda Bilginer, Asli Celebi Tayfur, Nesrin Besbas, Seza Ozen
Medical clowns: dream doctors as an important team member in the treatment of young children with juvenile idiopathic arthritis
P Hanuka, M Rotchild, A Gluzman, Y Uziel
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
SA Alfantaki, S Stavrou, A Siamopoulou-Mavridou
Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis
Yelda Bilginer, Eda Utine, Özgür Kasapçopur, Bora Gülhan, Erkan Demirkaya, Rezan Topaloğlu, Ali Düzova, Fatih Özaltın, Mehmet Alikaşifoğlu, Seza Özen
Radiological cervical spine involvement in polyarticular idiopathic juvenile arthritis
J Wipff, M Elhai, R Bazeli, A Feydy, A Kahan, C Job-Deslandre
Outcomes following corticosteroid injection for temporomandibular joint arthritis in juvenile idiopathis arthritis
E Smith, M Friswell
Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
NY Stepanenko
Paediatric rheumatology services through the parents’ eyes: a pilot study to develop a disease specific questionnaire to monitor deficiencies of care
A Thon, C Mokroß, F Dressler, K Stahl, W Günther, G Ullrich, G Steinkamp
Impact of a 2-yr anti-TNF treatment on the quality of life in JIA patients: a parent's/patient’s view
K Diafa, P Pratsidou-Gertsi, M Trachana, G Pardalos, F Kanakoudi-Tsakalidou
Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
M Nørgaard, T Herlin
Smallest detectable differences in clinical variables related to temporomandibular joint arthritis in juvenile idiopathic arthritis
Peter Stoustrup, Carlaberta Verna, Kasper D Kristensen, Annelise Küseler, Troels Herlin, Thomas K Pedersen
The effectiviness of an innovative web-based application to monitor HRQOL problems in paediatric rheumatology clinical practice
L Haverman, MAJ van Rossum, HSA Heymans, TW Kuijpers, MA Grootenhuis
Daily sleep quality and mood as predictors of pain in children with juvenile polyarticular arthritis
MH Bromberg, KM Gil, LE Schanberg
Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
Takako Miyamae, Tomo Nozawa, Masako Kikuchi, Toshitaka Kizawa, Tomoyuki Imagawa, Shumpei Yokota
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Maja Bulatović, Sebastiaan Vastert, Frederik Verweij, Nico Wulffraat, Femke van Wijk, Berent Prakken
Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD
AM Boldingh, EB Nordal
Autoimmune response following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis
Nadia E Aikawa, Claudia Goldenstein-Schainberg, M Vendramini, Lucia MA Campos, Carla G Saad, Julio B Moraes, Alberto Duarte, Alex R Precioso, Maria CST Timenetsky, E Bonfá, Clovis A Silva
Osteonecrosis of the femoral heads in patients with systemic onset juvenile idiopathic arthritis: comparison of the results of radiological and morphological methods
D Alexeev, I Nikishina, A Smirnov, L Semenova, L Bogjeva, S Makarov, S Radenska-Lopovok, D Ivanov
Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
O Nemiche, R Dagner, P Quartier, R Cimaz, O Richer, P Pillet, M Hofer
Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa
Kate Weakley, Monika Esser, Chris Ranier Pope, Christiaan Scott
The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
G Deslypere, C Wouters, J Joly, R Westhovens
Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
Boris Hugle, Susanne M Benseler
Impact of biologics on growth in children with juvenile idiopathic arthritis
F Uettwiller, G Pinto, M Polak, P Quartier
Turkish version of the pediatric quality of life inventory (PedsQL) 3.0 arthritis module: a reliability and validity study
Tarakci Ela, Baydogan Nilay, Kasapcopur Ozgur, Dirican Ahmet
QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
Bulent Koca, Ozgur Kasapcopur, Suleyman Bakari, Emre Celik, Ozden Calay
P wave dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
Bulent Koca, Ozgur Kasapcopur, Suleyman Bakari, Emre Celik, Ayse Guler Eroglu, Levent Saltik, Funda Oztunc, Ozden Calay
An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage
IP Nikishina, SR Rodionovskaya, AN Shapovalenko, LY Filippova, OM Kostareva
Prevalence and incidence of juvenile idiopathic arthritis in children in the republic of Bashkortostan: the epidemiological study
VA Malievskiy
Systemic juvenile idiopathic arthritis in the republic of Bashkortostan
VA Malievskiy
Maximal inter-incisal distance in healthy school children in Switzerland
H van Waes, C Langerweger, L Mueller, CJ Kellenberger, RK Saurenmann
Sleep disorders in patients with juvenile idiopathic arthritis as assessed by the sleep disturbance scale for children
RP Khubchandani, AA Bagde, A Pistorio, RP Hasija
The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis
M Trachana, P Triantafyllou, A Vraka, E Kaitalidou, P Pratsidou-Gertsi
Determing an “autoimmune” phenotype in systemic JIA
N Fischer, B Huegle, JP Haas
Enthesitis related arthritis- 2 distinct clinical phenotypes?
Corinne Fisher, John Ioannou, Debajit Sen
A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents
Seza Ozen, Yesim Aydin Son, Yener Tuncel, Erkan Demirkaya, Yelda Bilginer, Cengizhan Acikel, Bilge Volkan Salancı, Ozgur Kasapcopur, Erbil Unsal, Nesrin Besbas, Mehmet Alikasifoglu
2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?
Janneke Anink, Koert M Dolman, Merlijn J van den Berg, Mira van Veenendaal, Taco W Kuijpers, Marion AJ van Rossum
Validation of the juvenile artritis disease activity score in 1124 patient visits
LD de Vries, MW Heijstek, N Groot, M Bulatović, NM Wulffaat
Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
EB Nordal, M Zak, L Berntson, K Aalto, P Lahdenne, S Peltoniemi, S Nielsen, T Herlin, B Straume, A Fasth, M Rygg
Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
Adem Polat, Erkan Demirkaya, Turker Turker, Yelda Bilginer, Erbil Unsal, Muferet Erguven, Hakan Poyrazoglu, Ozgur Kasapcopur, Faysal Gok, Seza Ozen
Pain and impact of pain on function in JIA-patients aged 10-19 years
M Lanzinger
Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
Marco Gattorno, Aldo Naselli, Andrea Accogli, Sabrina Chiesa, Roberta Caorsi, Jessica Tebaldi, Antonella Buoncompagni, Nicola Ruperto, Stefania Viola, Paolo Picco, Angelo Ravelli, Alberto Martini
Longitudinal evaluation of bone mass in adolescents and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients
Falcini Fernanda, Stagi Stefano, Cavalli Loredana, Masi Laura, Capannini Serena, Ceri Lorenzo, Matucci Cerinic Marco, Brandi Maria Luisa
Does childhood health assessment questionnaire can predict outcome of patients with juvenile idiopathic arthritis?
G Susic, R Stojanovic, I Soldatovic, N Damjanov, G Radunovic
Relationship of serum ghrelin, leptin, resistin, adiponectin levels with nutritional status and inflammatory determinants in juvenile idiopathic arthritis
Sanem Eren, Oya Sayın, Balahan Makay, Tuncay Küme, Erbil Ünsal, Filiz Kuralay, Nur Arslan
Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
A Remesal, S Murias, MI Gonzalez, I Tarjuelo, R Merino
Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
S Murias, A Remesal, L Latorre, M Gomez, R Merino
Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
F De Benedetti, H Brunner, N Ruperto, R Schneider, P Woo, R Burgos-Vargas, P Dolezalova, R Joos, N Wulffraat, Z Zuber, F Zulian, R Allen, D Brown, J Chaitow, M Pardeo, G Espada, B Flato, V Gerloni, G Horneff, S Wright, A Kenwright, D Lovell, A Martini
Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
OU Konopelko, ES Zholobova, OS Rozvadovskaya
Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
J Vojinovic, A Furlan, N Damjanov, C D’Urzo, CA Dinarello
Early onset chronic arthritis associated with chromosome deletion 22 q11.2 syndrome. Is it juvenile idiophatic arthritis?
Esmeralda Nuñez, Pablo De Cabo, Gisela Diaz, Rocio Galindo, Antonio Urda
Coeliac disease and intestinal inflammation in juvenil idiopathic arthritis
Esmeralda Nuñez, Rocio Galindo, Enrique Lopez, Gisela Diaz, Maria Isabel Vicioso, Carlos Sierra
Etanercept improves pro-atherosclerotic biomarkers in children with juvenile idiopatic arthritis
De Sanctis Sara, Breda Luciana, Del Torto Marianna, Nozzi Manuela, Lucantoni Marta, Sebastiani Marianna, Mohn Angelika, Chiarelli Francesco
Preliminary data on insulin sensitivity in non-obese prepubertal children affected by juvenile idiopathic arthritis
Breda Luciana, Gaspari Stefania, De Sanctis Sara, Draghessi Antonella, Savino Alessandra, Scardapane Alessandra, Mohn Angelika, Chiarelli Francesco
DNase I levels and disease outcome in JIA patients treated with etanercept
D Lazarević, J Vojinović, G Sušić, N Damjanov, J Bašić
Mandibular ramus length and condylar changes in Juvenile Idiopathic Arthritis
P Arvonen, J Naujokaityte, M Arvonen, ML Perkiömäki, P Vähäsalo, P Pirttiniemi
Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients
L De Somer, K Lambot, C Wouters, B Bader-Meunier
Temporomandibular joint involvement (TMJ), a silent disease with severe alterations in young adulthood patients affected by juvenile idiophatic arthritis (JIA)
Falcini Fernanda, Melchiorre Daniela, Ceri Lorenzo, Capannini Serena, Denaro Valentina, Biondi Katia, Bosco Mario, Matucci Cerinic Marco
Juvenile idiopathic arthritis and Wegener granulomatosis: causal or casual relationship?
Balahan Makay, Tuba Tuncel, Nevin Uzuner, Erbil Ünsal
One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)
V Torrente-Segarra, P Santín, L Casas, S Ricart, R Bou, JB Ros, N Rodríguez, J Antón López
Mandibular distraction osteogenesis in patients with unilateral TMJ involvement in juvenile idiopathic arthritis
SE Nørholt, TK Pedersen, T Herlin
Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
I Melki, J Djadi-Prat, AM Prieur, C Job-Deslandre, P Quartier, C Elie, B Bader Meunier
Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels
Amita Aggarwal, Arpita Myles, Vishad Viswanath, Yogesh Preet Singh
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
O Vougiouka, E Atsali, C Panousi-Vlahou, S Azaris, A Koidou
German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA)
G Dueckers, N Guellac, M Arbogast, G Dannecker, I Foeldvari, M Frosch, G Ganser, A Heiligenhaus, G Horneff, A Illhardt, I Kopp, R Krauspe, B Markus, H Michels, M Schneider, W Singendonk, H Sitter, M Spamer, N Wagner, T Niehues
An Altered Peptide Ligand derived from heat-shock protein 60 induces regulatory T cells in JIA patients and suppresses adjuvant-induced arthritis
Dolores Cantera, Noraylis Lorenzo, Ariana Barberá, Amarys Alonso, Yamile Heredia, Elsy Chall, Lourdes Franco, Ramón G Padrón, Maria C Domínguez
Autologous stem cell transplantation in autoimmune arthritis restores immune homeostasis by renewal of the natural Treg compartment
T van den Broek, E Delemarre, J Meerding, E Wehrens, F Broere, N Wulffraat, M Boes, B Prakken, F van Wijk
Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)
PCE Hissink Muller, I Brederije, DMC Brinkman DMC, CF Allaart, LWA van Suijlekom-Smit, MAJ van Rossum, R ten Cate
MyastheniaGravis(MG) in a patient with Juvenile Idiopathic Arthritis
Christiaan Scott, Asgar Kalla
Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy
R Russo, M Katsicas
Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
FV Rokhlina, GA Novik, MF Dubko
Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report
MG Alpigiani, P Salvati, M Muraca, S Callegari, G Tripodi, R Lorini, MB Michelis, S Boero
Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
MG Alpigiani, P Salvati, S Callegari, A Bagnis, M Papadia, CE Traverso, R Lorini
Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
S Ricart, J Calzada, V Torrente, R Bou, J Anton
Long term follow-up after sudden withdrawal from a multicentric study of abatacept in juvenile idiopathic arthritis – data from the Portuguese cohort
S Melo Gomes, JA Melo Gomes
A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
E Demirkaya, N Ruperto, R Galasso, A Ravelli, E Palmisani, A Martini, A Pistorio
JIA affected sibling pairs present high correlation for ANA and ILAR category
G Filocamo, C Malattia, I Foeldvari, V Stanevicha, S Nielsen, T Herlin, C Pruunsild, F Zulian, Z Balogh, F Dressler, I Rumba, MG Alpigiani, E Cortis, F Falcini, R Trauzeddel, G Calcagno, L Lepore, M Alessio, DN Glass, SD Thompson, A Martini, N Ruperto
The PRINTO provisional definition of remission in juvenile dermatomyositis
D Lazarevic, A Pistorio, P Miettunen, A Ravelli, C Malattia, C Pilkington, N Wulffraat, S Garay, M Hofer, P Quartier, P Dolezalova, I Calvo Penades, V Ferriani, G Ganser, O Kasapcopur, JA Melo-Gomes, M Wierzbowska, A Martini, N Ruperto
Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
A Officioso, G Griso, C Storace, A Battagliese, R Carlomagno, M Alessio
A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
A Consolaro, G Filocamo, M Bertamino, E Palmisani, G Bracciolini, C Suffia, V Muratore, N Ruperto, A Martini, A Ravelli
Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
B Schiappapietra, A Consolaro, S Magni-Manzoni, N Solari, S Lanni, S Davì, S Pederzoli, G Bracciolini, A Martini, A Ravelli
Assessment of active TGFβ with a bioassay
Annemieke Laarhoven, Katja Heitink, Wilco de Jager, Berent Prakken, Femke van Wijk
Auto-antibody testing for children on biologic therapies for rheumatological conditions: results of audit
Julie Duncan, Jill Heath, Eileen Baildam, Gavin Cleary, Michael Beresford, Liza J McCann
Intra-articular corticosteroid therapy in oligoarticular juvenile arthritis: our clinical experience
C Trigilia, T Timpanaro, G Caff, G Belfiore, V Pavone, P Barone, R Garozzo
Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
G Horneff, S Fitter, HI Huppertz, I Foeldvari, K Kuemmerle-Deschner, R Kuester, N Tzaribacev, A Thon, M Borte, G Ganser, R Trauzeddel, K Minden
Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
E Alexeeva, R Denisova, S Valieva, T Bzarova, K Isayeva, T Sleptsova, E Mitenko
Adverse events of methotrexate treatment in JIA
J in ‘t Veld, NM Wulffraat, JF Swart
The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
Ristic Goran, Djokic Dragutin, Pasic Srdjan
An alternative analgesic agent for intra-articular corticosteroid injections (IAI) in juvenile idiopathic arthritis (JIA) – a fentanyl lollipop
Z Zareen, D Finn, O Killeen
Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
Ryoki Hara, Tomoyuki Imagawa, Takuma Hara, Masako Kikuchi, Takako Miyamae, Masaaki Mori, Shumpei Yokota
Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
JO Sato, TAP Fernandes, CB Nascimento, RG Brito, C Saad-Magalhães
Does standard phisiotherapy influence the health-related quality of life of JIA patients?
TMS Mendonça, CA Len, MTRA Terreri, CHM Silva, RMC Pinto
Evaluation of disease activity in a population of Russian JIA patients
OM Kostareva, IP Nikishina, SF Erdes, SO Salugina
Chronic exposure to Interleukin-6 amplifies the response to Toll-like receptor ligands: implication on the pathogenesis of macrophage activation syndrome
Raffaele Strippoli, Francesco Carvello, Roberta Scianaro, Loredana De Pasquale, Marina Vivarelli, Stefania Petrini, Luisa Bracci-Laudiero, Fabrizio De Benedetti
Fulminate mycoplasma infection and severe cutaneous vasculitis: an unusual presentation of complete MBL deficiency
Despoina Maritsi, M Al-Obadi, Alexandra Tabor, PA Brogan
Acceptability and practicality of pGALS musculoskeletal screening tool in Malawian children
E Smith, He Foster
A year in the life of the streptococcus
ET Mosley, AM McMahon, F Shackley, C Waruiru
Involvement of the heart in Kawasaki Disease: not always coronaritis
MC Pellegrin, A Taddio, N Giurici, L Lepore, A Ventura
CACP syndrome (Camptodactyly Arthropathy Coxa Vara Pericarditis). Clinical case
E Košková, E Vrtíková
Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience
EL Boulter, D Eleftheriou, NJ Sebire, C Edelsten, PA Brogan
Artherial thrombosis with antiphospholipid syndrome in 17 year old female patient: case of familial antiphospholipid syndrome
M Vidović, S Dobrota, D Perkov, Lj Banfić, K Putarek, K Starčević, M Jelušić-Dražić
Risk of latent tuberculosis in at-risk children with rheumatic diseases
SC Lim, JE Munro, RC Allen, N Curtis, JD Akikusa
Infliximab in the treatment of refractory uveitis. Does dose really matter?
MD Sukesh Sukumaran, MD Katherine Marzan, MD Andreas Reiff
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
G Simonini, A Taddio, M Cattalini, R Caputo, C DeLibero, I Pagnini, S Naviglio, L Lepore, R Cimaz
The Guadalajara-Camptodactyly Syndrome-an unusual case
RP Khubchandani, RP Hasija, M Dewoolkar
Suptypes of JIA have different susceptibility for developing pain amplification syndrome
N Draheim, J Reckzeh, L Croce, R Häfner, E Schnöbel-Müller, JP Haas
Epidemiology of uveitis in children over a 10 years period
Lydia Clarke, Yan Guex-Crosier, Michael Hofer
A case of pachydermodactyly in a 16 year-old male
J Madruga Dias, M Manuela Costa, J Romeu, L Soares de Almeida, P Filipe, JA Pereira da Silva
Are growing pains a parasomnia?
F Aeschlimann, H Werner, O Jenni, RK Saurenmann
Lethal chickenpox infection during treatment with infliximab and methotrexate
A Estmann, P Toftedal, AJ Schou
Current evidence of MTX efficacy in childhood chronic uveitis: a systematic review and meta-analysis
G Simonini, P Paudyal, G Jones, R Cimaz, GJ Macfarlane
Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
AJ Schou, P Toftedal, AE Christensen
Autoantibodies frequency in children with visceral leishmaniosis
Luciana Marques, Raquel Lisboa, Romana Maia
Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID)
MD Yepez Ricardo, MD Malagon Clara, Consuelo Romero-Sanchez, MD Mosquera Catalina
Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy
G Dueckers, K Siepermann, G Ganser, S Hardt, M Wennmacher, AE Horwitz, C Haneke, T Niehues
Manifestation of connective tissue diseases (CTD) in pediatrics patients with autoimmune hepatitis (AIH)
S Garay, M Mastri, A Besga, M Fabi, T Gonzalez Villar
Septic sacroiliitis in children-a diagnostic challenge
N Scotti, G Russo, R Carlomagno, C Forni, F Orlando, MG Della Casa, M Alessio
Raynaud's phenomenon in pediatric age
M Tavares, A Novo, H Sousa, I Silva, I Almeida, M Guedes
Various aspects of Kikuchi disease in three children: systemic or self-limited disease?
L Goffin, S Huybrechts, C Heijmans, AS Bouteiller, C Thomée, V Segers, MF Dehou, A Ferster
Predictive clinical and hematological factors in the differential diagnosis between malignancy and arthritis in children: a case-control study
Cristina Trigilia, Martina Barchitta, Tiziana Timpanaro, Silvia Marino, Rosaria Garozzo, Manuela La Rosa, Giovanna Russo, Antonella Agodi, Patrizia Barone, Andrea Di Cataldo
Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology
Daniel B Hawcutt, Clare Pain, Rachel Mulholland, Lisa M Cann, Gavin Cleary, Michael W Beresford, Eileen Baildam
Complementary and alternative medicine (CAM) in pediatric rheumatology: an European perspective
G Fadanelli, F Vittadello, G Martini, ME Zannin, G Zanon, F Zulian
Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
Jan-Inge Henter, AnnaCarin Horne, Bo Magnusson, Stefan Hagelberg
Evaluation of hypermobility syndrome associated with vesico-ureteric reflux in children
Reza Shiari, Reza Amir Askari, Masumeh Mohkam
Systemic Lupus Erythematosus complicated by Neuromyelitis Optica (Devic’s Syndrome): case series from a single paediatric rheumatology centre
Despoina Maritsi, Muthana Al-Obadi, Sonia Melo-Gomes, Kjell Tullus, Clarissa A Pilkington
Hematological features in children with systemic lupus erythematosus: are they more common than appreciated?
Muge Gokce, Nesrin Besbas, Yelda Bilginer, Mualla Cetin, Fatma Gumruk, Seza Ozen
Health related quality of life in juvenile SLE patients– use of the PedsQL 3.0 rheumatology module
Helena Sousa, Margarida Guedes
FDG-PET in juvenile systemic lupus erythematosus
M Alberdi, A Jørgensen, I Law, S Nielsen, MB Jørgensen
A Greek multicenter study comparing the clinical and immunologic phenotypes between adult and juvenile- onset lupus
P Nalbanti, S Stefanidou, S Alfantaki, A Siamopoulou, M Trachana, V Galanopoulou, P Pratsidou-Gerts, E Farmaki, F Papachristou, A Garyphallos, F Kanakoudi-Tsakalidou
Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
M Trachana, A Koutsonikoli, E Farmaki, N Printza, V Tzimouli, F Papachristou
Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE)
Joshua Pendl, Matt Hollander, Shannen Nelson, Wajeeha Yousaf, Nicola Ruperto, Michael Beresford, Marisa Klein-Gitelman, Marilynn Punaro, Anne Stevens, Tadej Avcin, Graciela Espada, Tsz-Leung Lee, Yu-Lung Lau, Jennifer Huggins, Esi Morgan-DeWitt, Hermine I Brunner
Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
C Jurado, B Bader-Meunier, B Ranchin, S Decramer, M Fischbac, E Bérard, F Saint-Marcoux
A case of generalized psoriasis-like skin lesions caused by rituximab use in a 14-years patient with systemic lupus erythematosus
SR Rodionovskaya, IP Nikishina, IN Tsymbal, IN Lavrentieva
Two different cases of SLE with neuropsychiatric manifestation
V Panaviene, S Rusoniene, M Jakutovic
Cross-sectional evaluation of bone mass in young adults with Juvenile Onset Systemic Lupus Erythematosus: the role of bone mass determinants in a large cohort of patients
Falcini Fernanda, Stagi Stefano, Cavalli Loredana, Capannini Serena, Masi Laura, Ceri Lorenzo, Denaro Valentina, Matucci Cerinic Marco, Brandi Maria Luisa
Acute adrenal failure (AAF) as the presenting symptom of primary antiphospholipid syndrome (APS)
G Russo, R Carlomagno, C Forni, L De Martino, D Capalbo, M Alessio
Bone mineral density in patients with juvenile systemic lupus erythematosus
Ana Paula Roenick Guenka, Blanca Bica, Laura Mendonça, Lucas Velloso, Mario Leitão
Liver involvement in juvenile systemic lupus erythematosus (SLE)
Generosa Mariniello, Giustina Russo, Raffaella Carlomagno, Rosalba Vitale, Maria Alessio
The role of kidney biopsy in a patient with juvenile SLE with no urine abnormity or no signs of renal failure
M Schüller, J Franova, M Macku
Penile anthropometry in adolescents and adults systemic lupus erythematosus
Ana P Vecchi, Eduardo F Borba, Eloísa Bonfá, Marcelo Cocuzza, Patrícia Pieri, Chong A Kim, Clovis A Silva
Systemic lupus erythematosus in Saudi children: Long-term outcome
Sulaiman M Al-Mayouf
Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study
P Miettunen, A Pistorio, A Ravelli, S Oliveira, M Alessio, R Cuttica, D Mihaylova, G Espada, S Pasic, E Cortis, S Ozen, O Porras, F Sztajnbok, E Palmisani, A Martini, N Ruperto
Plasmapheresis and Cyclophosphamide therapy in an eight year old girl with cerebral manifestation of systemic lupus erythematodes
A Ulbrich, I Lanator, D Csaicsich, MT Schmook, R Seidl, W Emminger
Biventricular systolic and diastolic function in a cohort of juvenile-onset systemic lupus erythematosus patients
Mariana Rodrigues, Luzia Sampaio, Cláudia Moura, Patrícia Costa, Iva Brito
Traditional cardiovascular risk factors in a cohort of juvenile-onset systemic lupus erythematosus (J-SLE)
Mariana Rodrigues, Luzia Sampaio, Cláudia Moura, Patrícia Costa, Iva Brito
Identification of predictors of bone mineral density trajectories in pediatric Systemic Lupus Erythematosus patients
SHL Lim, SM Benseler, PN Tyrrell, M Charron, ED Silverman
Infantile de novo primary antiphospholipid syndrome revealed by neonatal stroke
E Merlin, E Doré, S Chabrier, A Marques Verdier, JL Stéphan
Neuropsychiatric lupus in children
P Costa Reis, S Nativ, J Isgro, C Yildirim-Toruner, L Imundo, A Eichenfield
Age related clinical presentation and laboratory parameters in juvenile SLE: a Hungarian multicenter study
B Derfalvi, A Malik, M Kreko, K Pasti, T Tarr, G Marton, Zs Gyorke, B Mosdosi, Z Nyul, J Noll, I Csurke, F Harangi, Zs Balogh, I Orban, K Sevcic, E Kiss, R Kaposzta, B Szucs, S Turi, P Sallay, Gy Reusz, T Tulassay, AJ Szabo
Juvenile systemic lupus erythematosus: a retrospective study in a single center over a 13 years period
N Conejo, O Porras
Pediatric systemic lupus erythematosus and human parvovirus B19 infection
V Bélien-Pallet, S Sauvion, R Salomon, P Quartier, B Bader-Meunier
Lack of association of hepatitis C virus (HCV) antibodies and juvenile onset systemic lupus erythematosus (jSLE)
Cláudia Goldenstein-Schainberg, Ana P Nascimento, André LS Hayata, Eloisa Bonfá
Pathologic motion patterns in patients with progressive pseudorheumatoid arthropathy of childhood
M Hartmann, F Kreuzpointner, R Haefner, J-P Haas
TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
I Orbán, K Sevcic, EV Kiss
Usefulness of MRI in the follow-up of ERA-related sacroiliitis, and effectiveness of treatment with sulphasalazine
Ilaria Pagnini, Gabriele Simonini, Teresa Giani, Sara Savelli, Claudio Fonda, Rolando Cimaz
Transfer-consultations for young people: how do we do?
G Teilmann, K Boisen, J Pødenphant, M Zak, S Nielsen
Safety and efficacy of biological therapy with TNF-inhibitors and non TNF-inhibitors in a cohort of young adults affected by juvenile idiopathic arthritis (JIA): data from a single centre experience
Ceri Lorenzo, Falcini Fernanda, Fiori Ginevra, Capannini Serena, Matucci Cerinic Marco
Current attitude of rheumatology practitioners on transition and transfer from pediatric to adult health care
Deborah Hilderson, Philip Moons, Rene Westhovens, Carine Wouters
CLARITY: C hiL dhood A rthritis R isk Factor I dentification ST udY. Investigating the role of aberrant DNA methylation in juvenile idiopathic arthritis
JA Ellis, R Chavez, L Gordon, AL Ponsonby, B Lim, J Akikusa, R Allen, R Saffery, J Craig, JE Munro
Clinical heterogeneity among a three-generation Japanese family with D18N TREX1 mutation for Aicardi-Goutières syndrome / familial chilblain lupus
J Abe, R Nishikomori, K Izawa, T Awaya, T Kawai, T Yasumi, T Heike, N Hiragi, T Hiragi
Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
J Vojinovic, G Susic, D Lazarevic, J Basic, I Nikolic, N Damjanov
Differential expression of transcription factors predicted to regulate angiopoietin-1 and -2 genes is associated with specific angiopoietin signatures in RA and PsA synovial tissue
M Frleta, LGM van Baarsen, S Garcia-Perez, D de Launay, M Garrelfs, DM Gerlag, PP Tak, KA Reedquist
PD-1/PD-L1 signaling in JIA synovial regulatory T cell function
Sytze de Roock, Genoveva Keustermans, Chantal L Duurland, Ellen JM Wehrens, Femke van Wijk, Berent J Prakken
Increased stimulatory capacity of antigen presenting cells at the site of autoimmune inflammation interferes with regulatory T cell function
Femke Van Wijk, E Wehrens, C Duurland, B Vastert, M Klein, J Meerding, W De Jager, B Prakken
Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA)
A Hinks, J Cobb, P Martin, E Flynn, S Eyre, J Packham, A Barton, J Worthington, W Thomson
Association of the polymorphisms P53 gene with juvenile idiopathic arthritis in children Russian Fedration
Alexey N Kozhevnikov, Michael V Moskalenko, Nina A Pozdeeva, Margarita F Dubko, Valentina I Larionova, Gennagy A Novik
Phenotypic variation in familial chilblain lupus (FCL) and Aicardi-Goutières syndrome (AGS) associated with TREX1 mutation in 4 family members
James Glanville, Saleem Taibjee, Yanick Crow, Penny Davis, Clive Ryder, Taunton Southwood
Evidence for association of autoimmune genes with disabilty in juvenile idiopathic arthritis in a UK cohort
J Cobb, A Hinks, P Martin, E Flynn, R Carrasco, E Baildam, H Foster, J Gardner-Medwin, A Chieng, L Wedderburn, J Davidson, K Hyrich, W Thomson
B cell subsets phenotype in autoimmunity with immunodeficiency: analysis of a cohort of patients with APECED syndrome
A Magnani, A Meloni, M Gattorno, A Martini, E Traggiai
Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis
THCM Reinards, HM Albers, DMC Brinkman, SSM Kamphuis, MAJ van Rossum, EPAH Hoppenreijs, HJ Girschick, C Wouters, RK Saurenmann, JJ Houwing-Duistermaat, REM Toes, TWJ Huizinga, R ten Cate, MW Schilham
Association of the CCR5 Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
THCM Reinards, HM Albers, DMC Brinkman, SSM Kamphuis, MAJ van Rossum, EPAH Hoppenreijs, HJ Girschick, C Wouters, RK Saurenmann, JJ Houwing-Duistermaat, REM Toes, TWJ Huizinga, R ten Cate, MW Schilham
Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
AM Pesenacker, Stavroula Zavitsanou, Kiran Nistala, Lucy R Wedderburn
Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
Kim Ohl, Ralph Lippe, Eva Verjans, Nora Honke, Karin Maschke-Neuss, Norbert Wagner, Johannes Roth, Klaus Tenbrock
The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases
Olga Klochkova, Leila Namazova-Baranova, Ekaterina Alekseeva, Olga Kozhevnikova
NOD2/CARD 15 gene mutations in patients with Familial Mediterranean Fever
Y Berkun, A Karban, S Padeh, Y Shinar, E Pras, M Lidar, A Livneh, Y Bujanover
Diagnosis of NLRP3 somatic mosaicism in CINCA/NOMID patients using next-generation sequencing
K Izawa, R Nishikomori, N Tanikaze, MK Saito, R Goldbach-Mansky, I Aksentijevich, T Yasumi, T Kawai, T Nakahata, T Heike, O Ohara
Emperipolesis and cell death in NOD2-related Blau Syndrome and Crohn’s disease
Carl EI Janssen, Carlos D Rose, Antonio Naranjo, Brigitte Bader-Meunier, Rolando Cimaz, Miroslav Harjacek, Pierre Quartier, Rebecca TenCate, Caroline Thomee, Isabelle Cleynen, Tammy M Martin, Gert De Hertogh, Tania Roskams, Valeer J Desmet, Carine H Wouters
Granuloma-in-follicles in pediatric Crohn’s disease
Carl EI Janssen, Isabelle Cleynen, Gert De Hertogh, Valeer J Desmet, Tania Roskams, Carine H Wouters
The role of Inositol 1,4,5 triphosphate kinase C in the pathogenesis of Kawasaki disease
Vahid Khajoee, Rae SM Yeung
Oxidant and antioxidant status in children with juvenile idiopathic athritis
Hakan M Poyrazoglu, Ikbal Gökçek, Cevat Yazici, Ruhan Düsünsel, Zübeyde Gündüz, Ismail Dursun
PFAPA syndrome is linked to dysregulated IL-1β production
Laeticia Kolly, Annette von Scheven-Gete, Nathalie Busso, Nathaliane Bagnoud, Dirk Holzinger, Michael Morris, Michael Hofer
A validation of diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in Turkish children
Erkan Demirkaya, Cengizhan Acikel, Isabella Ceccherini, Seza Özen, Abdulbaki Karaoglu, Ismail Dursun, Betul Sozeri, Yelda Bilginer, Zubeyde Gunduz, Yusuf Tunca, Katerina Oikonomaki, Ioanna Varela, Francesco Caroli, Maria Pia Sormani, Marco Gattorno
Clavicular cortical hyperostosis: new autoinflammatory entity or part of the juvenile spondyloarthropathies clinical picture?
L Lamot, LT Bukovac, F Borovecki, K Vlahovicek, S Sumic, K Gotovac, F Bingula, M Harjacek
Novel mutation of the LPIN2 gene in Turkish brothers with Majeed syndrome. Response to IL-1 inhibition
T Herlin, M Bjerre, B Fiirgaard, G Kerndrup, H Hasle, P Ferguson
Prevalence of MEFV gene mutations in apparently healthy Slovenian and Macedonian population
M Debeljak, N Abazi, N Toplak, K Stavrić, M Kolnik, D Kuzmanovska, T Avčin
Impact of MEFV genotype in Caucasian children with periodic fever
Silvia Federici, G Calcagno, Martina Finetti, Romina Gallizzi, Antonella Meini, A Vitale, F Caroli, M Cattalini, Roberta Caorsi, Francesco Zulian, Alberto Tomasini, A Insalaco, J Frenkel, Mariapia Sormani, M Baldi, Isabella Ceccherini, Alberto Martini, Marco Gattorno
The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
N Toplak, J Frenkel, S Ozen, F De Benedetti, M Hofer, I Kone-Paut, H Girschick, B Neven, H Ozdogan, J Kummerle-Deschner, J Arostegui, A Simon, S Stojanov, R Vesely, C Wouters, V Hentgen, C Rose, P Dolezalova, H Lachmann, P Woo, I Touitou, A Martini, N Ruperto, M Gattorno
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease
L Cantarini, MG Brizi, G Simonini, T Giani, A Vitale, A Fioravanti, MR Bacarelli, M Galeazzi, R Cimaz
Significance of I313V mutation of NLPR3 gene in two pediatric patients
A Omenetti, R Antona, R Gallizzi, M Alessio, M Finetti, S Carta, A Rubartelli, A Martini, M Gattorno
Diversity in clinical manifestations of autoinflammatory syndromes
S Boiu, B Neven, S Compeyrot-Lacassagne, R Mouy, B Bader-Meunier, P Quartier
Deregulation of IL-1β axis in peripheral blood mononuclear cells from patients with Chronic Recurrent Multifocal Osteomyelitis
Roberta Scianaro, Antonella Insalaco, Giusi Prencipe, Luisa Bracci-Laudiero, Anna Maria Teti, Fabrizio De Benedetti
Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ?
B Bader-Meunier, S Fraitag, CEI Janssen, G de Saint Basile, K Brochard, N Brousse, C Bodemer, C Wouters
Evaluation of immune suppressive mechanisms in a murine model of familial hemophagocytic lymphohistiocytosis
Stéphanie Humblet-Baron, Adrian Liston
Genetic polymorphism of COL1A1 gene and bone mineralisation in juvenile idiopathic arthritis
MM Kostik, GS Demin, GV Stoyko, LA Scheplyagina, VI Larionova
Decreased osteoblastogenesis from synovial fluid progenitors as a marker of systemic inflammatory process in juvenile idiopathic arthritis
E Lazic Mosler, M Jelusic-Drazic, D Grcevic, A Marusic, N Kovacic
Rothmund-Thomson syndrome: Immuno-osseous challenges
I Meyts, L De Somer, X Bossuyt, M-A Morren, K Devriendt, C Wouters
Shwachman-Diamond Syndrome: frequent misdiagnosis as Jeune Syndrome and other peculiarities
I Meyts, H Schaballie, F Haerynck, L Sevenants, C Vermylen, V Bordon, X Bossuyt, A Corveleyn, A Uyttebroeck, M Renard
Peripheral joint ankylosis in the spontaneous model of arthritis in DBA/1 mice is genetically associated with BMP signaling
S Carter, I Derese, K Braem, AM Valdes, FP Luyten, RJ Lories
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis
L Cantarini, MG Brizi, G Simonini, T Giani, A Vitale, A Fioravanti, MR Bacarelli, Galeazzi Mauro, R Cimaz
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
R Joos, C Wouters, J Dehoorne, D Elewaut